EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)

Guillaume Roucoux iD, Frédérique Thonon, David Zucman, David Rey, Sophie Abgrall, Lars E Eriksson iD, Marie Préau, David Michels, Antoine Chéret, Martin Duracinsky

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0295223 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Guillaume Roucoux und 9 weiteren Autor:innen. Beteiligte Einrichtung: ECEVE, UMR-S 1123, Inserm, Université Paris Cité, Paris, France. Hauptthemen laut MEDLINE: COVID-19, HIV Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de Recherches sur le Sida et les Hépatites Virales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clinical research has focused on risk factors and treatment for severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), particularly in people with a comorbidity including the human immunodeficiency virus (HIV), but little attention has been paid to the care pathway. This article aims to show how living with HIV may have been a biopsychosocial burden or boost in care pathways for Covid-19.

Method

People living with HIV (PLHIV) from 9 clinical centers were invited to participate in this qualitative study. The sampling was purposive with a maximum variation in their sociodemographic profiles. Semi-structured interviews were conducted until data saturation, then coded for thematic analysis, using an inductive general approach.

Results

We interviewed 34 PLHIV of which 20 had SARS-COV-2 once. They were 24 males, 26 born in France; median age: 55. Twenty had a CD4 number above 500, and all were on antiretroviral therapy (ART). HIV appeared as a burden when Covid-19 symptoms reminded HIV seroconversion, fear of contamination, and triggered questions about ART effectiveness. HIV was not considered relevant when diagnosing Covid-19, caused fear of disclosure when participants sought SARS-COV-2 testing, and its care in hospitals was disrupted by the pandemic. ART-pill fatigue caused avoidance for Covid-19 treatment. As a boost, living with HIV led participants to observe symptoms, to get advice from healthcare professionals, and screening access through them. Some participants could accept the result of screening or a clinical diagnosis out of resilience. Some could consider ART or another drug prescribed by their HIV specialist help them to recover from Covid-19.

Conclusion

Living with HIV could function as a burden and/or a boost in the care pathways for Covid-19, according to patients’ relationship to their HIV history, comorbidities and representation of ART. Covid-19 in PLHIV needs further qualitative study to gain a more comprehensive assessment of the pandemic’s consequences on their lives and coping strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HIV InfectionsMaleHumansMiddle AgedHIVSARS-CoV-2COVID-19 Drug TreatmentCOVID-19 Testing

Autor:innen und Institutionen

  • ECEVE, UMR-S 1123, Inserm, Université Paris Cité, Paris, France.
  • Patient-Reported Outcomes Research (PROQOL), Unité de Recherche Clinique en Economie de la Santé (URC-ECO), Hôpital Hôtel-Dieu, AP-HP, Paris, France.
  • Foch Hospital, Suresnes, France.
  • Trait d'Union-Strasbourg University Hospitals, Strasbourg, France.
  • Hôpital Antoine Béclère, Service de Médecine Interne, Clamart, France.
  • UVSQ, INSERM U1018, CESP, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

ORCID-Profile: Guillaume Roucoux, Lars E Eriksson

Förderung

  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Zitieren

APA

Roucoux, G., Thonon, F., Zucman, D., Rey, D., Abgrall, S., Eriksson, L. E., Préau, M., Michels, D., Chéret, A., & Duracinsky, M. (2024). Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV). PLOS ONE. https://doi.org/10.1371/journal.pone.0295223

Vancouver

Roucoux G, Thonon F, Zucman D, Rey D, Abgrall S, Eriksson LE, et al. Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV). PLOS ONE. 2024. doi:10.1371/journal.pone.0295223

BibTeX
@article{Roucoux2024,
  author = {Roucoux, Guillaume and Thonon, Frédérique and Zucman, David and Rey, David and Abgrall, Sophie and Eriksson, Lars E and Préau, Marie and Michels, David and Chéret, Antoine and Duracinsky, Martin},
  title = {Questioning the “Ease” in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0295223}
}
Kostenlos starten →